Agilon Health (AGL) Expected to Announce Quarterly Earnings on Wednesday

Agilon Health (NYSE:AGL) is expected to release its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect Agilon Health to post earnings of ($0.27) per share and revenue of $1.4614 billion for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, February 25, 2026 at 4:30 PM ET.

Agilon Health Stock Down 1.9%

AGL stock opened at $0.35 on Wednesday. Agilon Health has a 52-week low of $0.34 and a 52-week high of $6.08. The stock has a market cap of $146.90 million, a price-to-earnings ratio of -0.47 and a beta of 0.06. The business has a fifty day moving average of $0.75 and a two-hundred day moving average of $0.88.

Hedge Funds Weigh In On Agilon Health

Institutional investors have recently modified their holdings of the business. LPL Financial LLC lifted its holdings in shares of Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares during the period. CIBC Bancorp USA Inc. acquired a new position in Agilon Health in the 3rd quarter valued at $34,000. Focus Partners Advisor Solutions LLC purchased a new position in Agilon Health during the 4th quarter worth $53,000. Tower Research Capital LLC TRC lifted its stake in shares of Agilon Health by 214.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company’s stock worth $85,000 after acquiring an additional 25,270 shares during the period. Finally, Captrust Financial Advisors boosted its holdings in shares of Agilon Health by 289.7% in the fourth quarter. Captrust Financial Advisors now owns 133,051 shares of the company’s stock valued at $92,000 after acquiring an additional 98,913 shares in the last quarter.

Trending Headlines about Agilon Health

Here are the key news stories impacting Agilon Health this week:

• Neutral Sentiment: Management will participate in upcoming investor events (Cowen Health Care Conference March 2 — webcast on the IR site — and Jefferies summit). This provides a near‑term opportunity for management to address investor questions and could supply fresh guidance/clarity. Read More.
• Negative Sentiment: Multiple law firms have filed or announced investigations and are soliciting lead plaintiffs in a securities‑fraud class action covering purchases between Feb. 26, 2025 and Aug. 4, 2025; many notices highlight a March 2, 2026 lead‑plaintiff deadline. These announcements increase the likelihood of litigation, potential legal costs, and management distraction—key reasons for downward pressure on the stock. Representative notices:
  Read More.,
  Read More.,
  Read More.,
  Read More.,
  Read More.,
  Read More.,
  Read More.,
  Read More.,
  Read More.,
  Read More.,
  Read More..

Analysts Set New Price Targets

AGL has been the topic of a number of recent research reports. Barclays cut their price target on shares of Agilon Health from $1.50 to $1.00 and set an “underweight” rating on the stock in a research note on Thursday, November 6th. Zacks Research upgraded shares of Agilon Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 21st. Wells Fargo & Company decreased their price target on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. BTIG Research reaffirmed a “neutral” rating on shares of Agilon Health in a research report on Friday, December 12th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research note on Wednesday, January 21st. Four equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Agilon Health presently has a consensus rating of “Hold” and a consensus price target of $2.71.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.